Abstract
Marketing drugs and devices to clinicians affects their prescribing behaviors, drives up health care costs, and increases risk of harm to patients. This article canvasses what clinicians and health professions students should know about undue influence of drug and device marketing on their practices. It also considers policy changes that would better protect patients and better situate clinicians to care for patients and communities in ways that are ethical, safe, and effective.
Original language | English (US) |
---|---|
Pages (from-to) | 681-686 |
Number of pages | 6 |
Journal | AMA Journal of Ethics |
Volume | 22 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2020 |
ASJC Scopus subject areas
- Issues, ethics and legal aspects
- Health(social science)
- Health Policy